Why Your Annual GP Check-Up Misses 80% of What Matters

A standard GP check-up in Switzerland typically covers the basics: blood pressure, weight, a lipid panel, perhaps blood glucose. In total, somewhere between 12 and 20 markers — out of the hundreds that circulate in your bloodstream telling a story about your health.

This is not a criticism of GPs. The system is designed for reactive care — treating what has already gone wrong. It was never designed to intercept what is quietly going wrong.

The 80% problem

Consider what a standard check-up does not typically measure:

• ApoB and ApoA1 — the markers that actually predict cardiovascular events, not just your total cholesterol
• Lipoprotein(a) — a genetically determined risk factor for heart attack that affects 1 in 5 people
• Fasting insulin and HOMA-IR — the only way to detect insulin resistance years before type 2 diabetes develops
• Free T3 and Free T4 — most GPs check TSH alone, missing subclinical thyroid dysfunction in millions of patients
• Cortisol and DHEA-S — the adrenal markers that explain why you feel exhausted even when your thyroid is "fine"
• hsCRP and IL-6 — systemic inflammation, the shared root of cardiovascular disease, dementia, and metabolic syndrome

Research published in The Lancet consistently shows that cardiovascular events, metabolic disease, and many cancers are preceded by detectable biological signals — often 5 to 10 years before the clinical diagnosis. The signals exist. Most check-ups simply don't look for them.

Why Swiss insurance doesn't cover the tests that matter

Switzerland's compulsory health insurance (KVG) is designed around cost-effectiveness at a population level. Preventative blood tests beyond a narrow standard set are generally not reimbursed for healthy, asymptomatic individuals. The logic is actuarial, not clinical.

This means that if you want to know whether your insulin sensitivity is declining, whether your testosterone is falling, or whether you have an elevated Lp(a) that triples your cardiac risk — you will need to arrange it yourself.

What the evidence says about early detection

A 2021 meta-analysis in NEJM Evidence found that individuals who received comprehensive metabolic and hormonal screening had a 42% lower incidence of late-stage cardiovascular events over a 10-year follow-up period. The intervention wasn't medication. It was knowledge, followed by targeted lifestyle and clinical intervention.

Early detection works because biology is not binary. Disease does not switch from "absent" to "present" overnight. It progresses along a continuum — and that continuum is measurable.

What a comprehensive panel actually looks like

At Aeonix, our Longevity Plus panel covers 80 validated biomarkers across cardiovascular, metabolic, hormonal, nutritional, inflammatory, oncological, and musculoskeletal domains. Our Elite panel extends this to 100+. Every result is reviewed by a qualified physician and returned within 48 hours.

The difference is not incremental. It is the difference between a snapshot and a film — between knowing your total cholesterol and knowing whether your arterial walls are actually at risk.

"Most people spend more time choosing a car than understanding the machine they will live in for the rest of their lives."

A comprehensive screening does not tell you what is wrong. More importantly, it tells you what is right — and what quiet changes are underway before they become clinical events. That knowledge is the beginning of everything.